ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Refractory Cancer · Recurrent Cancer · Solid Tumor, Adult · Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

Stanford Cancer Institute, Stanford, California, United States
Contact: Study coordinator (Allison Warner, MD) · allison.betof@stanford.edu
University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Sapna Patel, MD) · 720-848-0000
University of Miami Hospital and Clinics, Miami, Florida, United States
Study coordinator · CRSCutaneous@miami.edu · 305-243-2647
University of Chicago Medical Center, Chicago, Illinois, United States
Contact: Study coordinator (Katherine Kurnit, MD)
Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Oldadapo O. Yeku, MD. PhD) · 617-643-6158
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Alexander Shoushtari, MD) · shoushta@mskcc.org · 646-888-4161
Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus, Ohio, United States
Contact: Study coordinator (Casey Cosgrove, MD) · Casey.Cosgrove@osumc.edu
University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Janos Tanyi, MD, PhD) · Janos.Tanyi@pennmedicine.upenn.edu
Thomas Jefferson University, Honickman Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Rino Seedor, MD) · Rino.Seedor@jefferson.edu · 215-847-7409
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Anthony Olszanski, MD, RPh) · Anthony.Olszanski@fccc.edu
Contact: Principal Investigator (Anthony Olszanski, MD)
University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Diwakar Davar, M.D.) · davard@upmc.edu · 412-623-7368
Contact: Principal Investigator (Jason Luke, M.D.)
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Dejka M Araujo, M.D.) · daraujo@mdanderson.org · 713-792-3626
Contact: Principal Investigator (Dejka M Araujo, M.D.)
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Sylvia Lee, MD) · leesm@uw.edu
Universitätsklinikum Heidelberg, Nationales Centrum für Tumorerkrankungen (NCT), Heidelberg, Baden-Wurttemberg, Germany
Klinikum rechts der Isar der Technischen Universität München, Munich, Bavaria, Germany
Universitätsklinikum Würzburg, Würzburg, Bavaria, Germany
Universitätsklinikum Bonn - Medizinische Klinik III, Bonn, North Rhine-Westphalia, Germany
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Rhineland-Palatinate, Germany
Universitätsklinikum C.-G.-Carus Dresden, Dresden, Saxony, Germany
Charité Benjamin Franklin - Klinik für Hämatologie und Onkologie, Berlin, Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

מובילי המחקר

Cedrik Britten, M.D.
Study Director
Immatics US, Inc.

צפייה במקור ב־ClinicalTrials.gov פנייה לחוקר (אימייל)